chr19-44703406-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001039213.4(CEACAM16):c.95G>T(p.Ser32Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00161 in 1,613,786 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S32S) has been classified as Likely benign.
Frequency
Consequence
NM_001039213.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEACAM16 | NM_001039213.4 | c.95G>T | p.Ser32Ile | missense_variant | 3/7 | ENST00000587331.7 | NP_001034302.2 | |
CEACAM16 | XM_017026795.2 | c.95G>T | p.Ser32Ile | missense_variant | 2/5 | XP_016882284.1 | ||
CEACAM16-AS1 | NR_186815.1 | n.348-4229C>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEACAM16 | ENST00000587331.7 | c.95G>T | p.Ser32Ile | missense_variant | 3/7 | 1 | NM_001039213.4 | ENSP00000466561.1 |
Frequencies
GnomAD3 genomes AF: 0.00183 AC: 279AN: 152202Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00196 AC: 488AN: 248360Hom.: 3 AF XY: 0.00168 AC XY: 226AN XY: 134848
GnomAD4 exome AF: 0.00159 AC: 2327AN: 1461466Hom.: 6 Cov.: 32 AF XY: 0.00153 AC XY: 1116AN XY: 727034
GnomAD4 genome AF: 0.00182 AC: 277AN: 152320Hom.: 2 Cov.: 32 AF XY: 0.00177 AC XY: 132AN XY: 74490
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 30, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | CEACAM16: BP4, BS2 - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 14, 2015 | p.Ser32Ile in exon 3 of CEACAM16: This variant is not expected to have clinical significance because it has been identified in 0.9% (109/11536) of Latino chromo somes including 3 homozygotes by the Exome Aggregation Consortium (ExAC, http:// exac.broadinstitute.org; dbSNP rs186687142). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at